LC
DGX icon

Lindbrook Capital’s Quest Diagnostics DGX Stock Holding History

Lindbrook Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$97.3K Buy
575
+69
+14% +$11.3K 0.01% 690
2024
Q4 		$76.3K Buy
506
+33
+7% +$5.13K 0.01% 641
2024
Q3 		$73.4K Buy
473
+6
+1% +$896 0.01% 658
2024
Q2 		$63.9K Buy
467
+139
+42% +$19K 0.01% 698
2024
Q1 		$43.7K Sell
328
-87
-21% -$11.3K ﹤0.01% 827
2023
Q4 		$57.2K Buy
415
+227
+121% +$29.8K 0.01% 711
2023
Q3 		$22.9K Sell
188
-45
-19% -$6K ﹤0.01% 1006
2023
Q2 		$32.8K Sell
233
-85
-27% -$11.7K ﹤0.01% 864
2023
Q1 		$45K Buy
318
+38
+14% +$5.44K 0.01% 734
2022
Q4 		$43.8K Buy
280
+70
+33% +$10.1K 0.01% 743
2022
Q3 		$26K Sell
210
-194
-48% -$25.5K ﹤0.01% 873
2022
Q2 		$54K Buy
404
+32
+9% +$4.36K 0.01% 626
2022
Q1 		$51K Buy
372
+127
+52% +$17.7K 0.01% 664
2021
Q4 		$42K Buy
245
+94
+62% +$14.3K 0.01% 775
2021
Q3 		$22K Hold
151
– – 0.01% 702
2021
Q2 		$20K Hold
151
– – ﹤0.01% 779
2021
Q1 		$19K Buy
151
+4
+3% +$493 ﹤0.01% 763
2020
Q4 		$18K Hold
147
– – ﹤0.01% 715
2020
Q3 		$17K Buy
147
+5
+4% +$591 ﹤0.01% 667
2020
Q2 		$16K Sell
142
-93
-40% -$9.86K ﹤0.01% 682
2020
Q1 		$19K Buy
235
+39
+20% +$4.04K 0.01% 555
2019
Q4 		$21K Hold
196
– – 0.01% 720
2019
Q3 		$21K Buy
196
+42
+27% +$4.31K 0.01% 692
2019
Q2 		$15K Hold
154
– – 0.01% 772
2019
Q1 		$13K Hold
154
– – 0.01% 815
2018
Q4 		$12K Buy
+154
New +$14.4K 0.01% 774

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Lindbrook Capital's DGX Position: Q1 2025 in Review

Lindbrook Capital increased its Quest Diagnostics (DGX) stake by 14% in Q1 2025, buying an estimated $11.3K and bringing the position to 575 shares worth $97.3K. The position accounts for 0.01% of the portfolio, ranked #690.

Lindbrook Capital first reported a position in DGX in Q4 2018 and has held it in 26 quarters since. 968 funds tracked by Wall St. Rank hold DGX as of Q1 2025.

  • Lindbrook Capital held 575 shares of Quest Diagnostics worth $97.3K as of Q1 2025.
  • Lindbrook Capital bought 69 Quest Diagnostics shares in Q1 2025, an estimated $11.3K.
  • Quest Diagnostics made up 0.01% of Lindbrook Capital's portfolio in Q1 2025, its #690 holding.
  • Lindbrook Capital first reported a position in Quest Diagnostics in Q4 2018 and has held it in 26 quarters since.
  • 968 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.